Tacedinaline

DB12291InvestigationalSmall molecule

Tacedinaline has been used in trials studying the treatment of Lung Cancer, Multiple Myeloma, and Pancreatic Cancer.

Chemical structure of Tacedinaline
Mechanism
Curator reviewed
Formula / weight
C15H15N3O2 · 269.304 g/mol (avg)

Resolves to

Compound
UNIIUMF554N5FGCAS112522-64-2ChEMBLCHEMBL235191ChEBI90195PubChem2746
Structure
InChIKeyVAZAPHZUAVEOMC-UHFFFAOYSA-NSMILESCC(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1N
Targets
Q13547HDAC1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tacedinaline, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In